Arbet-Engels Christophe
CIK 0001802615
Chief Medical Officer
Filings
6
Latest Oct 3, 2025
Issuers covered
2
Showing
6 of 6
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +5.0% | +5.0% | +5.0% | +5.0% |
| 90 days | 1 | 100% | +60.9% | +60.9% | +60.9% | +60.9% |
| 180 days | 1 | 100% | +89.5% | +89.5% | +89.5% | +89.5% |
| 365 days | 1 | 100% | +74.7% | +74.7% | +74.7% | +74.7% |
Issuers
Companies where Arbet-Engels Christophe has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | 5 | Feb 14, 2025 |
| ALT | Altimmune, Inc. | 1 | Oct 3, 2025 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|